Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Porter

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Hematology. American Society of Hematology. Education Program|December 14, 2011
Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversiesDavid L Porter
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Advances in CAR T-cell therapy for chronic lymphocytic leukemiaDavid L Porter
Therapeutic Advances in Hematology|April 5, 2013
Cellular therapy following allogeneic stem-cell transplantationAlison Rager, David L Porter
Transplantation and Cellular Therapy|January 7, 2024
Past and Future Reflections and Profiles of a PioneerDavid L Porter, Robert Korngold
Comparative Cytogenetics|November 22, 2013
Cytogenetics of a parthenogenetic Arctic species of Micropsectra (Diptera, Chironomidae)David L Porter, Jon Martin
Blood|June 13, 2015
A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARsAnthony Mato, David L Porter
Leukemia & Lymphoma|March 23, 2002
Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantationJose Leis, David L Porter
Expert Opinion on Biological Therapy|November 23, 2013
CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the roadSaar Gill, David L Porter
Annual Review of Medicine|November 6, 2012
Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effectSaar Gill, David L Porter
American Journal of Hematology|November 18, 2015
CAR T-cells merge into the fast lane of cancer careNoelle V Frey, David L Porter
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Hematology. American Society of Hematology. Education Program|December 14, 2011
Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversiesDavid L Porter
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Advances in CAR T-cell therapy for chronic lymphocytic leukemiaDavid L Porter
Therapeutic Advances in Hematology|April 5, 2013
Cellular therapy following allogeneic stem-cell transplantationAlison Rager, David L Porter
Transplantation and Cellular Therapy|January 7, 2024
Past and Future Reflections and Profiles of a PioneerDavid L Porter, Robert Korngold
Comparative Cytogenetics|November 22, 2013
Cytogenetics of a parthenogenetic Arctic species of Micropsectra (Diptera, Chironomidae)David L Porter, Jon Martin
Blood|June 13, 2015
A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARsAnthony Mato, David L Porter
Leukemia & Lymphoma|March 23, 2002
Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantationJose Leis, David L Porter
Expert Opinion on Biological Therapy|November 23, 2013
CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the roadSaar Gill, David L Porter
Annual Review of Medicine|November 6, 2012
Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effectSaar Gill, David L Porter
American Journal of Hematology|November 18, 2015
CAR T-cells merge into the fast lane of cancer careNoelle V Frey, David L Porter
Pageof 20